Natsuko Kanazawa1, Norihiko Inoue1,2, Takuaki Tani1, Koichi Naito3, Hiromasa Horiguchi1, Kiyohide Fushimi1,2. 1. Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization, Tokyo, Japan. 2. Department of Health Policy and Informatics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. 3. Department of Physical Therapy, Faculty of Medical Sciences, Nagoya Women's University, Nagoya, Japan.
Abstract
Objectives: This study investigated the impact of the initial outbreak of coronavirus disease (COVID-19) on rehabilitation and functional outcomes of patients in Japanese hospitals. Methods: The study subjects were hospitals belonging to Japan's National Hospital Organization that provided inpatient care for patients with coronavirus COVID-19 during March-May 2020. We specifically focused on patients who were hospitalized for acute diseases, such as stroke, hip fracture, acute myocardial infarction, congestive heart failure, or chronic obstructive pulmonary disease, and received rehabilitation during hospitalization. Data were sourced from Japanese administrative data. The primary outcome was rehabilitation provision time in the target hospitals. The secondary outcomes were patient outcomes: rehabilitation participation time, length of hospital stay, 30-day readmission rate, and improvement of activities of daily living. Interrupted time series analysis was performed to evaluate the trend of rehabilitation provision time. Patient outcomes were compared with those for 2019. Results: The rehabilitation provision time for outpatients declined by 62% during the pandemic, while that for inpatients declined temporarily, and then increased. Compared with 2019 outcomes, rehabilitation participation time was longer and hospital stay length was shorter for stroke and hip-fracture patients, the 30-day readmission rate was increased for hip-fracture patients, and improvement of activities in daily living was less for patients with congestive heart failure who were totally dependent at admission. Other outcomes did not change. Conclusions: The findings suggest that during the initial COVID-19 pandemic, resources for rehabilitation were quickly reallocated to inpatient care, and the impact on inpatient outcomes was minimized. 2022 The Japanese Association of Rehabilitation Medicine.
Objectives: This study investigated the impact of the initial outbreak of coronavirus disease (COVID-19) on rehabilitation and functional outcomes of patients in Japanese hospitals. Methods: The study subjects were hospitals belonging to Japan's National Hospital Organization that provided inpatient care for patients with coronavirus COVID-19 during March-May 2020. We specifically focused on patients who were hospitalized for acute diseases, such as stroke, hip fracture, acute myocardial infarction, congestive heart failure, or chronic obstructive pulmonary disease, and received rehabilitation during hospitalization. Data were sourced from Japanese administrative data. The primary outcome was rehabilitation provision time in the target hospitals. The secondary outcomes were patient outcomes: rehabilitation participation time, length of hospital stay, 30-day readmission rate, and improvement of activities of daily living. Interrupted time series analysis was performed to evaluate the trend of rehabilitation provision time. Patient outcomes were compared with those for 2019. Results: The rehabilitation provision time for outpatients declined by 62% during the pandemic, while that for inpatients declined temporarily, and then increased. Compared with 2019 outcomes, rehabilitation participation time was longer and hospital stay length was shorter for stroke and hip-fracture patients, the 30-day readmission rate was increased for hip-fracture patients, and improvement of activities in daily living was less for patients with congestive heart failure who were totally dependent at admission. Other outcomes did not change. Conclusions: The findings suggest that during the initial COVID-19 pandemic, resources for rehabilitation were quickly reallocated to inpatient care, and the impact on inpatient outcomes was minimized. 2022 The Japanese Association of Rehabilitation Medicine.
Entities:
Keywords:
Asia; DPC data; claims data; healthcare policy; healthcare system
The first outbreak of coronavirus disease (COVID-19) in Japan occurred during March–May
2020. Since then, COVID-19 has remained as a prominent health and social problem. During the
worldwide pandemic, the provision of healthcare has been significantly affected.[1]) The number of hospitalizations for
various diseases has decreased in many countries,[2],[3],[4],[5],[6])
and some patient outcomes have changed during the pandemic.[7],[8]) During this period, healthcare providers and staff have faced
an excessive workplace burden because of measures taken to prevent nosocomial infections,
such as altering workflows, reallocating healthcare resources, and frequent use of personal
protective equipment.Special responses have also been required for the implementation of rehabilitation. This is
because physical contact between therapists and patients and the sharing of equipment
between patients occurs frequently in rehabilitation settings, which can cause
cross-infection. In many countries, inpatient rehabilitation has been offered in a reduced
capacity or only to patients with urgent needs, and outpatient rehabilitation programs have
been suspended and shifted to telerehabilitation.[9]) A group of international experts in cardiorespiratory
physiotherapy published clinical recommendations for managing physiotherapy during COVID-19
in March 2020.[10]) The
recommendations included screening for physiotherapy involvement for patients with COVID-19,
reallocation of healthcare resources, selection of patients eligible for rehabilitation, and
intervention. This guide was immediately translated into Japanese and disseminated
nationwide.For hospitalized patients, prolonged immobility results in delayed functional recovery,
extended hospitalization, and an increased risk of complication.[11],[12],[13]) Therefore, early and intensive mobilization and adequate
exercise should be implemented during hospitalization. In addition, to achieve functional
recovery and desirable outcomes, rehabilitation after hospital discharge plays a crucial
role.[14],[15],[16],[17]) During the pandemic, however, patients may have been
adversely affected because the implementation of rehabilitation was restricted.It is unclear how the COVID-19 pandemic has affected the implementation of rehabilitation
and whether patients’ functional outcomes have been affected. To investigate this, we
surveyed the provision of rehabilitation and functional outcomes in Japanese hospitals that
provided inpatient care for patients with COVID-19 during the first stage of the
pandemic.
MATERIALS AND METHODS
Data Source
We used insurance claims data and Diagnosis Procedure Combination (DPC) data of the
National Hospital Organization (NHO) of Japan, an organization established to manage
national hospitals across 140 locations nationwide. The DPC holds Japanese administrative
data, and its explicit content has been described in previous studies.[18]) Specifically, it contains
information on inpatient care, including patient profile, diagnoses, surgeries,
procedures, medications, and selected hospitalization information, such as Japan Coma
Scale[19]) at admission and
discharge, length of stay, discharge destination, and outcome. Diagnoses were recorded
based on the International Classification of Diseases Tenth Revision (ICD-10) codes.
Activities of daily living (ADL) scores based on the Barthel Index (BI) with a 20-point
scale were recorded at admission and discharge.[20])
Study Subjects
This study included data from 59 hospitals nationwide that provided inpatient care to
patients with COVID-19 during March–May 2020. We focused on patients who were admitted to
these hospitals because of acute diseases, such as stroke, hip fracture, acute myocardial
infarction (AMI), congestive heart failure (CHF), or chronic obstructive pulmonary disease
(COPD), and received rehabilitation during hospitalization. To examine the effect of the
pandemic on patient outcomes, patients with the same diseases during the same period of
the previous year were included as a control group.
Measurements
The primary outcome was the rehabilitation provision time in the target hospitals, which
was calculated as the total rehabilitation time provided to all patients based on
inpatient and outpatient claims data. To assess the time trend before the COVID-19
outbreak, we set an evaluation period from December 2019 to May 2020. The time was
calculated by summing the time provided in all the subject hospitals daily and was
evaluated for each inpatient and outpatient.The secondary outcomes were patient outcomes including rehabilitation participation time
per day, length of hospital stay, 30-day readmission, and improvement in ADL score during
hospitalization. These were assessed using the DPC data. An inpatient can receive a
rehabilitation program for up to 180 min per day. The rehabilitation participation time
per day was calculated by dividing the total rehabilitation participation time during
hospitalization by the number of days from the start of rehabilitation to discharge. The
30-day readmission was defined as an unplanned admission to the same hospital regardless
of the reason within 30 days of discharge. For evaluation of ADL scores, patients were
divided into three groups according to BI score at admission: total dependence group with
0 points, severe dependence group with 1–12 points, and moderate and slight dependence
group with 13–19 points.[21],[22]) For each group, differences between the scores on admission
and discharge were evaluated.This study was approved by the institutional review board of the NHO (R2-1119002). This
study used only anonymized data; therefore, informed consent was not required. However, a
public notice of the study was acknowledged on the NHO website, and the opportunity to opt
out was guaranteed.
Statistical Analysis
Continuous variables were expressed as means and standard errors or medians and
interquartile ranges, and categorical variables were expressed as percentages. Comparison
between the groups was performed using a t-test, Mann–Whitney U test, or
χ2 test.Interrupted time series (ITS) analysis was performed to analyze the trend of
rehabilitation provision time in the target hospitals.[23]) We divided the study period into three parts: (1)
pre-pandemic (December 1, 2019 to March 22, 2020; the period before the explosive increase
in COVID-19 cases); (2) pandemic (March 23 to May 16, 2020; the period during which the
number of new COVID-19 cases per day exceeded 50 and began increasing rapidly until it
fell below 50 and stopped declining); and (3) post-pandemic (May 17 to May 31, 2020). For
these three periods, we estimated the daily total rehabilitation time and the level
changes between two adjacent periods.Patient outcomes were analyzed for each disease group. Rehabilitation participation time
per day was averaged for each month based on the patient admission month and compared with
the same month last year, referring to an event study model.[24]) We fitted a multivariable ordinary least-squares
regression model to the outcome. We regressed rehabilitation participation time on
indicator variables for months, a binary categorical variable for the intervention year
group, and the interaction term between these two regressors.ADL improvement was analyzed for each disease group using a difference-in-difference
model. Statistical significance was set at P < 0.05. All statistical analyses were
performed using the Stata version 14 software (StataCorp, College Station, TX, USA).
RESULTS
A total of 59 hospitals included in this study were all acute-care hospitals [median number
of beds was 295 (interquartile range 140–430), including 9 hospitals with 500 or more beds].
Of these, 3 hospitals had beds for rehabilitation in the recovery phase, and 26 hospitals
had beds for long-term care for intractable neural disease. Of the 59 hospitals, 5 were
located in northern Japan (Hokkaido and Tohoku regions), 19 in eastern Japan (Kanto and
Shin-etsu regions), 7 in the middle of Japan (Tokai and Hokuriku regions), 16 in western
Japan (Kinki, Chugoku, and Shikoku regions), and 12 in southern Japan (Kyushu and Okinawa
regions). Twenty-eight hospitals were located in seven major cities where the spread of
COVID-19 was particularly severe in the first outbreak and were the first to be subjected to
emergency decelerations. A total of 2500 therapists including 1349 physical therapists, 811
occupational therapists, and 340 speech therapists, belonged to these hospitals. In total,
7847 patients were included in this study; 3793 patients were inpatients during the pandemic
period (March–May 2020), and 4054 patients were inpatients during the same period of 2019.
Patient characteristics were compared between groups of patients for each year (Table 1). When compared with 2019 data, the 2020
period showed more emergency admissions for stroke, a lower proportion of male patients with
hip fractures, and a lower mean age for COPD.
Table 1.
Patient characteristics by patient group in March-May 2020 and 2019
Stroke
Hip fracture
AMI
CHF
COPD
Variables
2019
2020
2019
2020
2019
2020
2019
2020
2019
2020
Total, n
1297
1222
1092
986
317
331
1032
1077
316
177
Age, years
76.0 (12.4)
75.8 (12.1)
81.6 (12.9)
81.8 (11.7)
71.0 (12.4)
71.7 (13.0)
82.1 (10.6)
81.6 (10.4)
77.4 (8.0)
75.0* (8.3)
Male, %
41.1
40.2
77.0
72.5*
29.0
28.4
49.3
46.2
17.7
14.1
JCS, %
0
45.0
46.6
86.4
85.7
88.0
87.6
82.1
84.0
90.2
87.6
1
41.1
40.4
13.3
13.8
7.6
8.5
14.4
12.6
7.6
9.0
2
10.5
9.2
0.3
0.4
1.3
1.8
2.4
2.4
1.6
0.6
3
3.4
3.8
0.1
0.1
3.2
2.1
1.1
0.9
0.6
2.8
Emergency, %
71.5
78.3*
70.7
73.6
96.2
97.6
72.8
74.7
41.5
42.4
Region, %
North
6.48
7.36
3.21
3.25
6.94
8.16
6.40
6.22
6.96
6.21
East
33.92
36.09
33.52
31.34
30.91
36.56
34.98
31.20
32.28
32.77
Middle
18.74
16.37
17.86
20.89
22.71
20.54
18.02
18.11
8.54
11.30
West
20.58
18.90
23.54
23.33
21.45
19.94
25.29
28.41
33.55
31.63
South
20.28
21.28
21.89
21.20
17.98
14.80
15.31
16.06
18.67
18.08
Data for Age given as mean (SD).
JCS, Japan Coma Scale. * Statistically significant difference, P <0.05.
Data for Age given as mean (SD).JCS, Japan Coma Scale. * Statistically significant difference, P <0.05.The daily rehabilitation provision time in the target hospitals was evaluated for each
inpatient and outpatient. The averaged data for each period are shown in Table 2. As a baseline condition, before the pandemic, the
rehabilitation provision time for outpatients accounted about for 6% of the total time for
inpatients and outpatients. The results of the ITS analysis for the rehabilitation provision
time per day in the subject hospitals are shown in Fig.
1 and Table 3. For outpatient
rehabilitation time, a decrease of approximately 10% was observed at the start of the
pandemic [−24.4 h, 95% confidence interval (CI) −48.2 to −0.5 h] (Fig. 1A), which was equivalent to a decrease of 24.8 min per
hospital. Moreover, during the pandemic period, a negative slope change was observed (−2.7 h
per day, 95% CI −3.7 to −1.7 h). This was equivalent to an additional decrease of 2.7 min
per day per hospital from the baseline trend. At the end of the pandemic period, outpatient
rehabilitation time was reduced by 62% from the baseline trend. Thereafter, in the
post-pandemic period, there was a positive slope change from the pandemic period (5.4 h per
day, 95% CI 4.3 to 6.6 h, equivalent to 5.5 min per day per hospital). For inpatient
rehabilitation, although it temporarily decreased by about 7% (−314 h, 95% CI −398 to −230
h) at the start of the pandemic (equivalent to −5.3 h per hospital), the slope positively
changed in the pandemic period by 9.2 h per day from the baseline trend (equivalent to 9.4
min per day per hospital). The increasing trend continued after the pandemic, and it was
higher than that in the pre-pandemic period by the end of the study period (Fig. 1B). The trend of the total rehabilitation
provision time for inpatients and outpatients was similar to that for inpatients. It
temporarily decreased by about 7% (−338 h, 95% CI −424 to −253 h) at the start of the
pandemic (equivalent to −5.7 h per hospital) and then continued to increase throughout the
pandemic and post-pandemic periods (Fig. 1C).
Table 2.
Daily rehabilitation provision time during pre-pandemic, pandemic, and
post-pandemic period
Period
Outpatient
Inpatient
Overall
Pre-pandemic, h
264.6 (38.1)
4368.0 (122.3)
4632.6 (123.7)
(per hospital)
4.5 (0.6)
74.0 (2.1)
78.5 (2.1)
Pandemic, h
150.6 (44.2)
4288.4 (154.4)
4439.0 (123.9)
(per hospital)
2.6 (0.7)
72.7 (2.6)
75.2 (2.1)
Post-pandemic, h
138.9 (28.2)
4625.2 (92.4)
4764.0 (113.3)
(per hospital)
2.4 (0.5)
78.4 (1.6)
80.7 (1.9)
Data given as mean (SD). Mean hours per hospital was calculated by dividing hours in
the cell above by 59 target hospitals.
Fig. 1.
The trends of daily hours of rehabilitation provided in all hospitals.
The dots in the figure show the total hours of rehabilitation performed in all
hospitals for each day. (A) Outpatient rehabilitation; (B) inpatient rehabilitation; (C)
inpatient and outpatient rehabilitation. Three periods were set: before, during, and
after the pandemic. Subsequently, interrupted time series analysis was performed, and
regression lines were fitted for each period (black lines).
Table 3.
Results of interrupted time series analysis for the trend of rehabilitation
provision time during December 2019 to May 2020
Outpatient rehabilitation
Inpatient rehabilitation
Overall
Variables
Coef.
95% CI
P value
Coef.
95% CI
P value
Coef.
95% CI
P value
Baseline trend, h/day
−0.8
(−1.1, −0.4)
<0.001
1.4
(0.2, 2.6)
0.026
0.6
(−0.6, 1.8)
0.348
Slope change, h/day
Pandemic
−2.7
(−3.7, −1.7)
<0.001
9.2
(5.7, 12.7)
<0.001
6.5
(2.9, 10.1)
0.001
Post-pandemic
2.7
(1.5, 3.9)
<0.001
7.0
(2.9, 11.2)
0.001
9.8
(5.5, 14.0)
<0.001
Difference between pandemic and post-pandemic
5.4
(4.3, 6.6)
<0.001
−2.2
(−6.4, 2.1)
0.314
3.3
(−0.9, 7.4)
0.125
Level change, h
At start of pandemic
−24.4
(−48.2, −0.5)
0.046
−313.9
(−398.0, −229.8)
<0.001
−338.3
(−423.7, −252.8)
<0.001
At end of pandemic
23.1
(0.4, 45.8)
0.046
11.0
(−72.3, 94.2)
0.793
34.1
(−47.2, 115.4)
0.405
The pre-pandemic period was from December 1, 2019, to March 22, 2020. The pandemic
period was from March 23 to May 16, 2020. The post-pandemic period was from May 17 to
May 31, 2022. Coef., coefficient.
Data given as mean (SD). Mean hours per hospital was calculated by dividing hours in
the cell above by 59 target hospitals.The trends of daily hours of rehabilitation provided in all hospitals.The dots in the figure show the total hours of rehabilitation performed in all
hospitals for each day. (A) Outpatient rehabilitation; (B) inpatient rehabilitation; (C)
inpatient and outpatient rehabilitation. Three periods were set: before, during, and
after the pandemic. Subsequently, interrupted time series analysis was performed, and
regression lines were fitted for each period (black lines).The pre-pandemic period was from December 1, 2019, to March 22, 2020. The pandemic
period was from March 23 to May 16, 2020. The post-pandemic period was from May 17 to
May 31, 2022. Coef., coefficient.The rehabilitation participation time per day for the patients was also evaluated by
disease group. For patients with stroke or hip fracture, rehabilitation participation time
per day was longer in April and May than in the previous year (Fig. 2A, B). The respective
differences were 8.4 and 6.8 min per day for patients with stroke and 2.6 and 3.2 min per
day for patients with hip fractures. The daily rehabilitation participation time was 6 min
longer in May for patients with AMI (Fig. 2C) and
3.4 min longer in both March and May for patients with CHF (Fig. 2D). For patients with COPD, there was no statistically
significant difference in any month (Fig. 2E).
Fig. 2.
Rehabilitation participation time per day by patient group.
The rehabilitation participation time per day was calculated by dividing the total time
of rehabilitation participation time during hospitalization by the number of days from
the start of rehabilitation to discharge.
Asterisks indicate difference for the month between years.
Rehabilitation participation time per day by patient group.The rehabilitation participation time per day was calculated by dividing the total time
of rehabilitation participation time during hospitalization by the number of days from
the start of rehabilitation to discharge.Asterisks indicate difference for the month between years.Figure 3 shows that the length of hospital stay
was significantly shorter in 2020 than that in the previous year for patients in stroke and
hip fracture groups (median difference was 2 days in each group).
Fig. 3.
Length of hospital stay during the COVID-19 pandemic and previous year by patient
group.
The boxes are bordered at the 25th and 75th percentiles, with
the middle line at the 50th percentile.
Asterisks indicate that hospital stays in 2020 were significantly shorter than in
2019.
Length of hospital stay during the COVID-19 pandemic and previous year by patient
group.The boxes are bordered at the 25th and 75th percentiles, withthe middle line at the 50th percentile.Asterisks indicate that hospital stays in 2020 were significantly shorter than in
2019.However, no significant difference was observed for the AMI, CHF, or COPD groups.Figure 4 shows little change between years for
the 30-day readmission rates for the respective disease groups. However, the 30-day
readmission rate for patients with hip fractures in 2020 was significantly higher than in
the previous year, with a difference of 1.5 points. Specifically, the readmission rate among
these patients discharged to nursing homes increased from 2.3% in 2019 to 9.3% during the
pandemic (P=0.02). The readmission rate for other patients discharged to home or transferred
to other medical facilities were 2.1% and 1.8% in 2019 and 3.5% and 2.3% in 2020 (none were
significantly different). The distribution of discharge destinations remained unchanged from
the previous year for all groups (Table 4).
Fig. 4.
Thirty-day readmission rate during the COVID-19 pandemic and previous year by patient
group.
Blue bars indicate rates during March–May 2019; red bars
indicate rates for the same period in 2020.
Asterisk indicates that the rate in 2020 was significantly higher than in 2019.
Table 4.
Barthel Index and discharge destination by patient group in March–May 2020 and
2019.
Stroke
Hip fracture
AMI
CHF
COPD
Variables
2019
2020
2019
2020
2019
2020
2019
2020
2019
2020
Discharge destination, %
Home
47.1
47.2
20.1
17.3
88.3
84.3
69.1
72.2
86.7
77.4
Hospital transfer
44.3
45.3
66.6
70.7
8.2
9.4
14.1
14.4
7.3
14.1
Nursing home
4.8
4.4
11.8
11.0
1.9
2.4
8.3
7.8
1.6
3.4
Death
3.9
3.0
1.4
0.9
1.6
3.9
8.4
5.6
4.1
5.1
Other
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.3
0.0
Barthel Index, mean (SD)
At admission
9.44 (8.07)
9.42 (8.12)
4.30 (6.12)
4.13 (5.86)
10.48 (8.91)
9.29 (8.95)
11.31 (8.16)
11.60 (8.14)
15.62 (6.56)
14.35 (7.20)
At discharge
13.40 (8.00)
12.80 (8.03)
9.37 (7.12)
9.07 (6.83)
18.31 (4.64)
17.82 (5.17)
15.33 (6.60)
14.89 (6.96)
17.44 (5.30)
16.85 (5.72)
Barthel Index is represented on a 20-point scale.
Thirty-day readmission rate during the COVID-19 pandemic and previous year by patient
group.Blue bars indicate rates during March–May 2019; red barsindicate rates for the same period in 2020.Asterisk indicates that the rate in 2020 was significantly higher than in 2019.Barthel Index is represented on a 20-point scale.There was no change in ADL score improvement years for all disease groups (Table 4). However, only the mean score of total
dependence group in patients with CHF was significantly less than that of the same group in
the previous year, with a difference of 2.2 points (Fig.
5). The same trend was observed in the total dependence group for COPD, with a
difference of 3.7 points, although this was not significant.
Fig. 5.
Improvement in ADL scores by patient group.
The status of ADL was reported at admission and discharge based on the BI. ADL score
improvement was evaluated by classifying patients into three groups based on BI at
admission: Group 1, total dependence patients with a score of 0 at admission; Group 2,
severe dependence patients with a score of 1–12 at admission; Group 3, moderate and
slight dependence patients with a score of 13–19 at admission. The differences between
the COVID-19 pandemic period (March–May 2020, solid lines) and the same period of the
previous year (March–May 2019, dotted lines) were analyzed using a
difference-in-differences model.
Asterisk denotes significant difference.
Improvement in ADL scores by patient group.The status of ADL was reported at admission and discharge based on the BI. ADL score
improvement was evaluated by classifying patients into three groups based on BI at
admission: Group 1, total dependence patients with a score of 0 at admission; Group 2,
severe dependence patients with a score of 1–12 at admission; Group 3, moderate and
slight dependence patients with a score of 13–19 at admission. The differences between
the COVID-19 pandemic period (March–May 2020, solid lines) and the same period of the
previous year (March–May 2019, dotted lines) were analyzed using a
difference-in-differences model.Asterisk denotes significant difference.
DISCUSSION
This study evaluated the impact of the initial COVID-19 pandemic outbreak on the provision
of rehabilitation in 59 hospitals in Japan. The results showed that the provision time for
outpatient rehabilitation showed a decreasing trend, whereas that for inpatients showed an
increasing trend. In addition, for patients divided into groups based on treatment for
stroke, hip fracture, AMI, CHF, or COPD, some of the patient groups showed changes in some
outcomes such as ADL improvement, length of stay, and 30-day readmission. To the best of our
knowledge, this is the first report of a nationwide study of rehabilitation practices and
patient outcomes during the COVID-19 pandemic. Although the scale of the first outbreak was
much smaller than those of subsequent outbreaks (Supplemental Fig. S1), at that
time, the characteristics of the disease itself were unknown and personal protective
equipment was not readily available, causing confusion in the healthcare delivery system in
hospitals. Therefore, it is necessary to clarify how the rehabilitation of non-COVID-19
patients was affected under these circumstances. Furthermore, understanding impacts on
patient outcomes will provide essential knowledge for further research and valuable insights
for future countermeasures against large-scale epidemics and disasters.Our results showed that rehabilitation for outpatients was undoubtedly limited in the first
outbreak of the COVID-19 pandemic. This is consistent with recommendations made by the Japan
association of rehabilitation hospitals and institutions that suggested the suspension of
rehabilitation for outpatients. This implies that the hospitals and their medical staff paid
attention to the recommendations and complied with them. Moreover, the nationwide
declaration of a state of emergency from April 16 to May 25, 2020 restricted the scope of
social and daily life, and patients refraining from visiting hospitals to avoid the risk of
infection may also have contributed to this result.[25])In contrast, rehabilitation of inpatients showed an increasing trend, which can be
attributed to the resources typically reserved for outpatient rehabilitation being
temporarily shifted to rehabilitation of inpatients. This response corresponds to that of
many other countries.[9]) As a
result, the total rehabilitation duration provided in hospitals did not change
significantly. This may indicate that the rehabilitation departments of hospitals that took
care of patients with COVID-19 were able to successfully reallocate resources and provide
rehabilitation without loss of function even during the pandemic.Focusing on the patient groups, the rehabilitation participation time for stroke and hip
fractures increased during the pandemic period. This suggests that these patients, who
especially needed early intervention for functional recovery and prevention of
complications, were given priority in assigning the available resources. These groups also
had shorter hospital stays than in the previous year. During this period, although the
proportions of patients with COVID-19 among all inpatients were not high (about 1% in March,
3% in April, and 2% in May), a large part of the workforce was devoted to securing beds and
personnel in preparation for providing medical care for patients with COVID-19. Outpatient
care was suspended whenever possible, and inpatient care was also drastically restricted by
postponing scheduled admissions unless it was an emergency. In addition, inpatients were
encouraged to discharge from the hospital as early as possible to prevent cross-infection
within the hospital. Particularly for patients with stroke or hip fracture, the Japanese
medical system has established care plan coordination between acute hospitals and
communities, rehabilitation hospitals, and long-term care facilities, which is reported to
contribute to shortened hospital stay.[26],[27]) Our results indicate that the coordination was strongly
promoted and probably worked effectively during the pandemic.However, the 30-day readmission rate for patients with hip fractures during the pandemic
was worse than that in the same period during the previous year. Given that post-discharge
facility-based training improves physical function,[28]) suspension of outpatient rehabilitation and inactivity
during the pandemic may have contributed to the increased readmission rate. In particular,
the increase in readmission rate from the previous year for these patients discharged to
nursing homes was evidently higher than that for those discharged elsewhere. Considering
that a previous study reported that discharge to a nursing home is a related factor of
readmission,[29]) and the
distribution of discharge destinations remained unchanged from the previous year, our
results suggest that discharge to a nursing home was more strongly related to readmission in
the pandemic situation. However, further studies are required in this area because the
reason for readmission was not assessed in the current study.In the evaluation of ADL improvement, no difference was observed between years when
comparing the mean BI scores of all inpatients. However, by dividing patients into three
groups based on the level of ADL dependence, it was possible to identify differences in the
impact in each group. Our results showed that ADL improvement in the total dependence group
of patients with CHF was less than that in the previous year. A similar trend was observed
in the group of patients with COPD. Patients with these diseases often demonstrate muscle
catabolism and wasting.[30],[31]) In particular, the total dependence group may have been
suffering from more severe skeletal muscle dysfunction because of prolonged bed rest.
Dysfunction of ADL among these patients is often caused by a decline in cardiopulmonary
function, muscular endurance, and functional capacity,[32]) and exercise is strongly recommended for a beneficial
outcome in such cases.[33])
However, the circumstances of the COVID-19 pandemic may have forced patients to train at the
bedside, where equipment, facilities, and space are minimal, resulting in inadequate
training and unsatisfactory results. However, the content or location of rehabilitation
training was not observed in this study, and further detailed studies are needed. The other
groups achieved ADL improvements comparable with those of the previous year, indicating that
patients were not disadvantaged in this aspect during the pandemic. These results allowed us
to understand which patients were more likely to be disadvantaged and require special
consideration when similar situations arise in the future.The current study has some limitations. First, we could not evaluate the impact on
outpatient outcomes. Interruption of outpatient programs could adversely impact
patients,[34],[35],[36]) and further studies are needed to confirm this
assumption. Subsequently, the results of the present study were based on nationwide data
from multiple centers in Japan. Therefore, the validity of generalizing these results to
other countries or situations is unknown. Next, we compared the patient outcomes in the
COVID-19 pandemic period with those of the same period in the previous year to evaluate the
impact of the pandemic. However, the patient outcomes in the previous year might not have
been fully representative of the status of ordinary conditions. Lastly, the number of
therapists who were engaged in the rehabilitation of patients with COVID-19 during this
period was unknown. Therapists who engaged in rehabilitation for patients with COVID-19
often did not rehabilitation for non-COVID-19 patients on the same day to prevent nosocomial
infections. This protocol may have affected the level of rehabilitation available for
non-COVID-19 patients. However, the degree of impact of this factor was not evaluated.
CONCLUSION
During the 3 months of the first outbreak of the COVID-19 pandemic in Japan, a reduced
level of rehabilitation was provided to outpatients, as recommended by the expert
association, while rehabilitation for inpatients was slightly increased. These findings
suggest that in emergency situations, priority was given to ensuring the safety of patients
and therapists, and resources were swiftly reallocated to inpatient care. Moreover, the
impact on patient outcomes was minimized in this situation. When faced with similar public
health problems in the future, the findings of this study may provide essential resources
for addressing these problems. In the future, more detailed studies will be required to
assess the relationship between rehabilitation practices and patient outcomes.Number of daily cases of COVID-19 in March–May 2020 in Japan.
Authors: Toby B Cumming; Amanda G Thrift; Janice M Collier; Leonid Churilov; Helen M Dewey; Geoffrey A Donnan; Julie Bernhardt Journal: Stroke Date: 2010-12-09 Impact factor: 7.914
Authors: Peter Thomas; Claire Baldwin; Bernie Bissett; Ianthe Boden; Rik Gosselink; Catherine L Granger; Carol Hodgson; Alice Ym Jones; Michelle E Kho; Rachael Moses; George Ntoumenopoulos; Selina M Parry; Shane Patman; Lisa van der Lee Journal: J Physiother Date: 2020-03-30 Impact factor: 7.000
Authors: I Laffont; A Gelis; C Balva; I Tavares; M Julia; F Pradalier; F Feuvrier; A Benhadid; S Fazilleau; J Masson; C Jourdan; A Dupeyron; C Duflos Journal: Ann Phys Rehabil Med Date: 2021-04-30
Authors: Viral A Sagar; Edward J Davies; Simon Briscoe; Andrew J S Coats; Hasnain M Dalal; Fiona Lough; Karen Rees; Sally Singh; Rod S Taylor Journal: Open Heart Date: 2015-01-28
Authors: Elisabeth Stöhr; Adem Aksoy; Meghan Campbell; Muntadher Al Zaidi; Can Öztürk; Julia Vorloeper; Jonas Lange; Atsushi Sugiura; Nihal Wilde; Marc Ulrich Becher; Christian Diepenseifen; Ulrich Heister; Georg Nickenig; Sebastian Zimmer; Vedat Tiyerili Journal: PLoS One Date: 2020-11-20 Impact factor: 3.240